LAB vs NVDA · rev $174.4M vs P/E 58, rev $96.22B
Standard Biotools Inc (LAB) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
LAB currently screens at market cap $317.1M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the LAB and NVDA stock pages for the full models.
Not investment advice.